International Business Machines (IBM)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 224.60 |
|---|---|
| 52-week range | 175.28 – 292.65 |
| Return, 1 month / 3 months | +12.6% / +18.6% |
| Return, 1 year / 3 years | −13.2% / +84.2% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 50.4% |
| Worst drawdown (1 year) | -35.3% |
| Average daily value traded | 0.76M EUR |
| Dividend yield | 2.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
International Business Machines, commonly called IBM, is a technology company based in the United States. It supplies computer hardware, software and information technology services to businesses, government bodies and other large organisations around the world. Its offerings include mainframe computers, servers, data storage systems, cloud computing services, consulting and artificial intelligence software. IBM also provides support and outsourcing services that help customers run and modernise their technology operations.
The shares are listed on the Deutsche Börse Xetra in Germany under the code IBM, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
International Business Machines (IBM) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 224.60 on 27 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 339 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 13.2% and over the last three months it rose 18.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.2% | ||
| From 52-week high | -20.2% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 18.6% | ||
| 6-month return | 17.1% | ||
| 12-month return, skipping the last month | -22.9% | ||
| Stability (higher is calmer) | 32 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 50.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -35.3% | ||
| Liquidity | 69 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.76M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 69 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.4% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +5.6% |
|---|---|
| 1 month | +12.6% |
| 3 months | +18.6% |
| 6 months | +17.1% |
| 1 year | −13.2% |
| 3 years | +84.2% |
| 5 years | +162.7% |
Signals
| 50-day / 200-day average | 204.62 / 213.57 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.81 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Aug 2026 | USD 1.5033 |
| 8 May 2026 | USD 1.5033 |
| 10 Feb 2026 | USD 1.4944 |
| 10 Nov 2025 | USD 1.4944 |
| 8 Aug 2025 | USD 1.4944 |
| 9 May 2025 | USD 1.4944 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.